In re Biovail Corp. Securities Litigation

247 F.R.D. 71, 2007 U.S. Dist. LEXIS 9522, 2007 WL 403056
District Court, S.D. New York·Decided February 5, 2007·No. No. 03 CV 8917 (RO)·Published·Cited by 2 cases

Opinion

MEMORANDUM & ORDER

OWEN, District Judge.

At a hearing on October 13, 2006, the Court denied plaintiffs’ Motion To Unseal the Second Amended Class Action Complaint. Plaintiffs now move the Court to reconsider that denial.

To satisfy the standards governing motions for reconsideration, a movant must [72]*72show that the Court has overlooked controlling decisions or factual matters that, had they been considered, might reasonably have altered the result. See Range Road Music, Inc. v. Music Sales Corp., 90 F.Supp.2d 390, 391-92 (S.D.N.Y.2000). A motion to reconsider is “not a motion to reargue those issues already considered when a party does not like the way the original motion was resolved.” In re Houbigant, Inc., 914 F.Supp. 997, 1001 (S.D.N.Y.1996).

Lead Plaintiffs do not persuade me that revisiting the legal or factual issues addressed in the prior motion would alter the outcome or that the Court overlooked controlling legal authority. The Stipulated Protective Order dated April 29, 2005, which both plaintiffs and defendant signed, at paragraph 18 describes a process whereby a party can contest the designation of certain material as “Confidential.” At the October 13 hearing, the Court invited the plaintiffs to follow this procedure. Transcript at 23. Plaintiffs have not done so. If they believe documents have incorrectly been designated by defendant as “Confidential,” they may file a motion challenging such designation following the procedures outlined above. Upon such a motion, the Court will be properly situated to decide the validity of the “Confidential” designation attributed to each document.1 The motion for reconsideration is denied.

So Ordered.

Free access — add to your briefcase to read the full text and ask questions with AI

In re Biovail Corp. Securities Litigation, 247 F.R.D. 71, 2007 U.S. Dist. LEXIS 9522, 2007 WL 403056 (S.D.N.Y. 2007).

247 F.R.D. 71 (In re Biovail Corp. Securities Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related